Sep 24, 2020 (Baystreet.ca via COMTEX) -- More shakings from the health-care industry, where GoodRx /zigman2/quotes/221104301/composite GDRX -3.07% , a company out of Santa Monica, Calif., which finds users prescription drugs at a discount, closed up 53% in its public debut Wednesday on the NASDAQ
The stock closed Wednesday at $50.50 per share, up from its IPO price of $33 per share, boosting its market cap to about $19.4 billion.
Founded in 2011 by Facebook /zigman2/quotes/205064656/composite FB +2.33% veteran Doug Hirsch and software entrepreneur Trevor Bezdek, GoodRx offers users a free list of discount cards and coupons to cut down costs of their prescription medication. The company collects fees from the pharmacy benefits managers it works with.
It's the latest tech company to go public in a busy month for IPOs, following Snowflake /zigman2/quotes/220991541/composite SNOW -4.10% , Unity /zigman2/quotes/221035391/composite U -1.20% and Amwell /zigman2/quotes/220991557/composite AMWL +2.13% . Data analytics company Palantir is expected to go public in a direct listing on Sept. 30. GoodRx revealed in its filing to go public last month that it has been consistently profitable since 2016, a rare feat for tech startups going public.
The company said it earned $55 million in profit for first half of 2020, up from $31 million in the first half of 2019. Revenues for the first half of 2020 were $257 million, up from $173 million in the first half of 2019. In 2019, it pulled in $66 million in profit on $388 million in revenue.
Morgan Stanley, Goldman Sachs and JP Morgan led the IPO, while investors include Silver Lake, Francisco Partners and Spectrum Equity,
The shares opened Thursday down $1.31, or 2.6%, to $49.19.
Is there a problem with this press release? Contact the source provider Comtex at firstname.lastname@example.org. You can also contact MarketWatch Customer Service via our Customer Center.